A bacteriophage journey at the European Medicines Agency.

A bacteriophage journey at the European Medicines Agency.

Item
http://www.wikidata.org/entity/Q38560900
Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting DiseasesBacteriophage formulated into a range of semisolid and solid dosage forms maintain lytic capacity against isolated cutaneous and opportunistic oral bacteria.Phage Therapy in a 16-Year-Old Boy with Netherton Syndrome.Refractory Pseudomonas Bacteremia in a 2-Year-Old Sterilized by Bacteriophage Therapy."French Phage Network"-Second Meeting ReportNimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells.Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?Guidelines to Compose an Ideal Bacteriophage Cocktail.Silk Route to the Acceptance and Re-Implementation of Bacteriophage Therapy-Part II.1st German Phage Symposium-Conference Report.Semi-Solid and Solid Dosage Forms for the Delivery of Phage Therapy to Epithelia.
P2860

A bacteriophage journey at the European Medicines Agency.

Item
http://www.wikidata.org/entity/Q38560900
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A bacteriophage journey at the European Medicines Agency.
@en
type
label
A bacteriophage journey at the European Medicines Agency.
@en
prefLabel
A bacteriophage journey at the European Medicines Agency.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
A bacteriophage journey at the European Medicines Agency.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932